Analysis of the Western European Next Generation Sequencing (NGS) Market

Clinical Applications Grow, Regulations Stiffen, Acquisitions Mount
Share this:
     
Published: 11 Jun 2014

This study explores Western Europe’s dynamic next generation sequencing (NGS) market. The majority of the quantitative and qualitative information was acquired through primary research conducted with NGS providers. The market is broadly classified into 2 major segments: instruments and reagents, and 2 subsegments: research use only and clinical diagnostic use. Geographic segmentation covers the United Kingdom, Germany, France, Spain, Italy, Benelux, and Scandinavia. Also, the study includes a competitive analysis (SWOT), product analysis, revenue forecasts, and market share using a base year of 2013 and a 2014–2018 forecast period. A list of key sequencing service providers for each country or region is included.

  1.  
  2.  
  3.  
  4.  
  5.  
  6.  
  7.  
  8.  
  9.  
  10.  
  11.  
  12.  
  13.  
  14.  
  15.  
  16.  

Tools

Features of this research

SUBSCRIPTIONS

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..